Prothena Corporation PLC PRTA.OQ PRTA.O is expected to show a rise in quarterly revenue when it reports results on February 20 for the period ending December 31 2024
The Dublin Ireland; Republic of-based company is expected to report a 2,284.1% increase in revenue to $7.534 million from $316 thousand a year ago, according to the mean estimate from 9 analysts, based on LSEG data.
LSEG's mean analyst estimate for Prothena Corporation PLC is for a loss of $1.04 per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Prothena Corporation PLC is $40.00, above its last closing price of $14.17.
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Sep. 30 2024 | -1.17 | -1.18 | -1.10 | Beat | 6.6 |
Jun. 30 2024 | -1.02 | -1.05 | 1.22 | Beat | 215.8 |
Mar. 31 2024 | -1.20 | -1.20 | -1.34 | Missed | -11.6 |
Dec. 31 2023 | -1.24 | -1.22 | -1.26 | Missed | -3.6 |
Sep. 30 2023 | -0.35 | -0.32 | 0.38 | Beat | 218 |
Jun. 30 2023 | -1.10 | -1.00 | -1.03 | Missed | -3.4 |
Mar. 31 2023 | -0.98 | -0.94 | -0.89 | Beat | 5.8 |
Dec. 31 2022 | -0.42 | -0.47 | 0.12 | Beat | 125.8 |
This summary was machine generated February 18 at 21:55 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。